Taizhou Crene Biotechnology Co., Ltd.
                                                                                                           
Verified Supplier
19 Years
Since 2007
Menu
Chemicals Other Chemicals

Cas 946414-94-4 Nivolumab Monoclonal Antibodies For Breast Cancer

Price Negotiable
Price: Negotiable
MOQ: 1g
Delivery Time: Negotiable
Brand: Crene
Product Description

Cas 946414-94-4 Nivolumab Monoclonal Antibodies For Breast Cancer

 

Chemical Information
Product name:Nivolumab Purity:99% min
CAS NO:946414-94-4 Solubility:Soluble in DMSO
Molecular Formula:C6362H9862N1712O1995S42 Package:Package according to customer requirements
Molecular Weight:143.6 kg/mol Storage:Store at -20℃
Quality control
COA
Remarks

Nivolumab is a medication used to treat cancer. It is used as a first line treatment for inoperable or metastatic melanoma in combination with ipilimumab if the cancer does not have a mutation in BRAF,as a second-line treatment following treatment with ipilimumab and if the cancer has a mutation in BRAF, with a BRAF inhibitor,[as a second-line treatment for squamous non-small cell lung cancer, and as a second-line treatment for renal cell carcinoma.

 

 

Related Products:

Alirocumab; Denosumab; Eculizumab; Evolocumab; Omalizumab; Ustekinumab; Vedolizumab; Trastuzumab; Omalizumab; Denosumab; Cetuximab; Bevacizumab; Aflibercept

References
[1]. Wang C, et al. In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates. Cancer Immunol Res. 2014 Sep;2(9):846-56.

Get in Touch

Have questions about our products or want to discuss a custom order? Our team is ready to help you.

Company Taizhou Crene Biotechnology Co., Ltd.
Location Add: Economic Developed Zone of Taizhou Zhejiang China.

Request A Quote

Please check your email address.
Your message must be at least 20 characters.